BIO-Europe Spring EBD Group BIO Image Map
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe Spring® 2015 Presenting Companies

23andMe United States   Connect on partnering360  
Discovery Platform | 09:15, Tuesday, March 10 | Level 0 | Room D
AbbVie United States Visit their website Connect on partnering360  
Large Pharma | 17:15, Monday, March 9 | Level 0 | Room E
Alexion Pharmaceuticals United States Visit their website Connect on partnering360  
Large Pharma | 17:45, Monday, March 9 | Level 0 | Room E
ALMIRALL Spain Visit their website Connect on partnering360  
Midsize Pharma | 14:45, Tuesday, March 10 | Level 0 | Room D
Amgen United States Visit their website Connect on partnering360  
Large Pharma | 13:45, Monday, March 9 | Level 0 | Room E
ANERGIS SA Switzerland Visit their website Connect on partnering360  
Respiratory | 17:15, Tuesday, March 10 | Level 0 | Room C
AP-HP Tech Transfer France      
Academic Innovators | 10:30, Tuesday, March 10 | Level 0 | Room E
Apceth Germany Visit their website Connect on partnering360  
Cancer | 12:15, Tuesday, March 10 | Level 0 | Room C
Aptalis Pharmaceutical Technologies Italy Visit their website Connect on partnering360  
Midsize Pharma | 15:00, Tuesday, March 10 | Level 0 | Room D
Ariana Pharma France Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 14:00, Tuesday, March 10 | Level 0 | Room E
ArmaGen, Inc. United States Visit their website Connect on partnering360  
CNS/Neurology | 12:00, Tuesday, March 10 | Level 0 | Room E
AstraZeneca United Kingdom Visit their website Connect on partnering360  
Large Pharma | 14:15, Monday, March 9 | Level 0 | Room E
Avexxin AS Norway Visit their website Connect on partnering360  
Autoimmune/Inflammation | 16:15, Tuesday, March 10 | Level 0 | Room C
Avraham Pharmaceuticals Israel Visit their website Connect on partnering360  
Next Generation - CNS/Neurology | 11:50, Tuesday, March 10 | Level 0 | Room D
Bayer HealthCare Germany Visit their website Connect on partnering360  
Large Pharma | 15:15, Monday, March 9 | Level 0 | Room E
Benitec Biopharma Australia Visit their website Connect on partnering360  
RNA Therapeutics/Gene Therapy | 10:45, Tuesday, March 10 | Level 0 | Room E
BioNTech AG Germany Visit their website Connect on partnering360  
Cancer | 11:15, Tuesday, March 10 | Level 0 | Room C
Bionure Inc United States Visit their website Connect on partnering360  
Ophthalmology | 17:15, Tuesday, March 10 | Level 0 | Room D
BIOTEM France Visit their website Connect on partnering360  
Antibodies | 10:00, Tuesday, March 10 | Level 0 | Room D
Biouniversa s.r.l. Italy Visit their website Connect on partnering360  
Next Generation - Cancer | 10:50, Tuesday, March 10 | Level 0 | Room D
Boehringer Ingelheim Biopharmaceuticals GmbH Germany Visit their website Connect on partnering360  
Service/CMO | 15:00, Tuesday, March 10 | Level 0 | Room E
Bone Therapeutics Belgium Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 10:15, Wednesday, March 11 | Level 0 | Room C
Calypso Biotech SA Switzerland Visit their website Connect on partnering360  
Next Generation | 11:00, Tuesday, March 10 | Level 0 | Room D
CEA France Visit their website    
Academic Innovators | 09:00, Tuesday, March 10 | Level 0 | Room E
Cellectar Biosciences, Inc. United States Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 10:45, Wednesday, March 11 | Level 0 | Room C
Cellspace France      
Academic Innovators | 09:10, Tuesday, March 10 | Level 0 | Room E
Cloud Pharmaceuticals United States Visit their website    
Discovery Platform | 09:30, Tuesday, March 10 | Level 0 | Room D
CMC Biologics United States Visit their website Connect on partnering360  
Service/CMO | 15:30, Tuesday, March 10 | Level 0 | Room E
Critical Outcome Technologies Canada Visit their website Connect on partnering360  
Cancer | 14:45, Tuesday, March 10 | Level 0 | Room C
CureVac Germany Visit their website Connect on partnering360  
Vaccines | 16:15, Tuesday, March 10 | Level 0 | Room E
Cynapsus Therapeutics Inc. Canada Visit their website Connect on partnering360  
CNS/Neurology | 12:45, Tuesday, March 10 | Level 0 | Room E
Cytonet GmbH & Co. KG Germany Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 10:00, Wednesday, March 11 | Level 0 | Room C
Debiopharm International S.A. Switzerland Visit their website Connect on partnering360  
Midsize Pharma | 15:30, Tuesday, March 10 | Level 0 | Room D
Dicerna Pharmaceuticals United States Visit their website Connect on partnering360  
RNA Therapeutics/Gene Therapy | 11:00, Tuesday, March 10 | Level 0 | Room E
Domain Therapeutics France Visit their website Connect on partnering360  
CNS/Neurology | 12:30, Tuesday, March 10 | Level 0 | Room E
Eli Lilly and Company United States Visit their website Connect on partnering360  
Large Pharma | 17:30, Monday, March 9 | Level 0 | Room E
Emmaus Medical, Inc. United States Visit their website Connect on partnering360  
Next Generation - Cardiovascular | 11:40, Tuesday, March 10 | Level 0 | Room D
Emulate / Wyss Institute for Biologically Inspired Engineering United States Visit their website Connect on partnering360  
Next Generation - Enabling Technologies | 12:20, Tuesday, March 10 | Level 0 | Room D
Erytech Pharma France Visit their website Connect on partnering360  
Cancer | 14:00, Tuesday, March10 | Level 0 | Room C
Eukarÿs France Visit their website Connect on partnering360  
RNA Thereputics/Gene Therapy | 11:15, Tuesday, March 10 | Level 0 | Room E
Eyevensys SAS France   Connect on partnering360  
Regen Med/Advanced Therapies | 09:15, Wednesday, March 11 | Level 0 | Room C
Functional Enviromics Technologies, S.A. Portugal Visit their website Connect on partnering360  
Next Generation - Service/CMO | 12:40, Tuesday, March 10 | Level 0 | Room D
Galena Biopharma, Inc. United States Visit their website Connect on partnering360  
Cancer | 11:30, Tuesday, March 10 | Level 0 | Room C
Gene Signal SA Switzerland Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 09:30, Wednesday, March 11 | Level 0 | Room C
Genentech United States Visit their website Connect on partnering360  
Large Pharma | 15:00, Monday, March 9 | Level 0 | Room E
Genmab Denmark Visit their website Connect on partnering360  
Antibodies | 09:45, Tuesday, March 10 | Level 0 | Room D
Gensight Biologics France Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 09:00, Wednesday, March 11 | Level 0 | Room C
Glycotope Biotechnology GmbH Germany Visit their website Connect on partnering360  
Enabling Technologies | 16:30, Tuesday, March 10 | Level 0 | Room E
Grünenthal GmbH Germany Visit their website Connect on partnering360  
Midsize Pharma | 16:30, Tuesday, March 10 | Level 0 | Room D
Hansa Medical AB Sweden Visit their website Connect on partnering360  
Autoimmune/Inflammation | 15:45, Tuesday, March 10 | Level 0 | Room C
Histide AG Switzerland Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 11:30, Wednesday, March 11 | Level 0 | Room C
HoneyLab Ltd New Zealand Visit their website Connect on partnering360  
Next Generation - Dermatology | 12:10, Tuesday, March 10 | Level 0 | Room D
Horizon Pharma plc Ireland Visit their website Connect on partnering360  
Midsize Pharma | 15:15, Tuesday, March 10 | Level 0 | Room D
HRA Pharma France Visit their website Connect on partnering360  
Midsize Pharma | 14:00, Tuesday, March 10 | Level 0 | Room D
Humanetics Corporation United States Visit their website Connect on partnering360  
Cancer | 09:00, Tuesday, March 10 | Level 0 | Room C
iCeutica United States Visit their website Connect on partnering360  
Delivery | 17:30, Tuesday, March 10 | Level 0 | Room D
immatics biotechnologies GmbH Germany   Connect on partnering360  
Cancer | 10:45, Tuesday, March 10 | Level 0 | Room C
Immunomic Therapeutics United States Visit their website Connect on partnering360  
Vaccines | 16:00, Tuesday, March 10 | Level 0 | Room E
ImmuPharma France Visit their website Connect on partnering360  
Autoimmune/Inflammation | 15:30, Tuesday, March 10 | Level 0 | Room C
INSERM Transfert France Visit their website Connect on partnering360  
Academic Innovators | 09:20, Tuesday, March 10 | Level 0 | Room E
InSight Biopharmaceuticals Israel Visit their website Connect on partnering360  
Antibodies | 10:15, Tuesday, March 10 | Level 0 | Room D
Institut Pasteur France Visit their website Connect on partnering360  
Academic Innovators | 09:30, Tuesday, March 10 | Level 0 | Room E
Ipsen Biopharm Limited United Kingdom Visit their website Connect on partnering360  
Midsize Pharma | 16:15, Tuesday, March 10 | Level 0 | Room D
Johnson & Johnson United States Visit their website Connect on partnering360  
Large Pharma | 14:30, Monday, March 9 | Level 0 | Room E
Kancera AB Sweden Visit their website Connect on partnering360  
Cancer | 09:15, Tuesday, March 10 | Level 0 | Room C
KineMed, Inc. United States Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 14:45, Tuesday, March 10 | Level 0 | Room E
Lipopharma Therapeutics Spain Visit their website Connect on partnering360  
Next Generation - Cancer | 12:50, Tuesday, March 10 | Level 0 | Room D
Lonza Switzerland Visit their website Connect on partnering360  
Service/CMO | 15:15, Tuesday, March 10 | Level 0 | Room E
Luzitin, Bluepharma Group Portugal Visit their website Connect on partnering360  
Cancer | 12:30, Tuesday, March 10 | Level 0 | Room C
Mayoly Spindler France Visit their website Connect on partnering360  
Midsize Pharma | 16:00, Tuesday, March 10 | Level 0 | Room D
Meabco A/S Denmark Visit their website Connect on partnering360  
Cancer | 15:15, Tuesday, March 10 | Level 0 | Room C
MediVector, Inc. United States Visit their website Connect on partnering360  
Infectious Disease | 17:00, Tuesday, March 10 | Level 0 | Room D
Merck Serono, a division of Merck KGaA Germany Visit their website Connect on partnering360  
Large Pharma | 16:15, Monday, March 9 | Level 0 | Room E
Metys Pharmaceuticals Switzerland Visit their website Connect on partnering360  
Cancer | 12:00, Tuesday, March 10 | Level 0 | Room C
MicroBiome Therapeutics United States Visit their website Connect on partnering360  
Next Generation - GI/Metabolic/Diabetes | 12:30, Tuesday, March 10 | Level 0 | Room D
Milestone Pharmaceuticals Inc. Canada Visit their website Connect on partnering360  
Cardiovascular | 11:30, Tuesday, March 10 | Level 0 | Room E
MorphoSys AG Germany Visit their website Connect on partnering360  
Cancer | 11:45, Tuesday, March 10 | Level 0 | Room C
MSD United States Visit their website Connect on partnering360  
Large Pharma | 16:30, Monday, March 9 | Level 0 | Room E
NANOBIOTIX France Visit their website Connect on partnering360  
Cancer | 09:30, Tuesday, March 10 | Level 0 | Room C
NEOVACS France Visit their website Connect on partnering360  
Autoimmune/Inflammation | 16:30, Tuesday, March 10 | Level 0 | Room C
Neurotar Ltd. Finland Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 14:15, Tuesday, March 10 | Level 0 | Room E
Novartis Pharma Switzerland Visit their website Connect on partnering360  
Large Pharma | 15:45, Monday, March 9 | Level 0 | Room E
Novimmune S.A. Switzerland Visit their website Connect on partnering360  
Autoimmune/Inflammation | 16:45, Tuesday, March 10 | Level 0 | Room C
Novo Nordisk Denmark Visit their website Connect on partnering360  
Large Pharma | 17:00, Monday, March 9 | Level 0 | Room E
ObsEva SA Switzerland Visit their website Connect on partnering360  
OB/GYN | 17:45, Tuesday, March 10 | Level 0 | Room D
oncgnostics GmbH Germany Visit their website Connect on partnering360  
Next Generation - Biomarkers/Diagnostics/Imaging | 10:30, Tuesday, March 10 | Level 0 | Room D
OncoLogica Ltd United Kingdom Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 14:30, Tuesday, March 10 | Level 0 | Room E
Oncopeptides Sweden Visit their website Connect on partnering360  
Cancer | 10:15, Tuesday, March 10 | Level 0 | Room C
Oncothyreon Inc. United States Visit their website Connect on partnering360  
Cancer | 10:30, Tuesday, March 10 | Level 0 | Room C
ORYX Translational Medicine Germany Visit their website Connect on partnering360  
Cancer | 09:45, Tuesay, March 10 | Level 0 | Room C
OsseoMatrix France Visit their website    
Next Generation - Regen Med/Advanced Therapies | 11:20, Tuesday, March 10 | Level 0 | Room D
Oxford BioMedica United Kingdom Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 10:30, Wednesday, March 11 | Level 0 | Room C
PDC*line Pharma France Visit their website Connect on partnering360  
Next Generation - Cancer | 11:10, Tuesday, March 10 | Level 0 | Room D
PFEnex United States Visit their website Connect on partnering360  
Biosimilars | 16:45, Tuesday, March 10 | Level 0 | Room D
Pfizer United States Visit their website Connect on partnering360  
Large Pharma | 14:00, Monday, March 9 | Level 0 | Room E
PharmAbcine Inc. Korea, South Visit their website Connect on partnering360  
Cancer | 11:00, Tuesday, March 10 | Level 0 | Room C
Pieris Germany Visit their website Connect on partnering360  
Respiratory | 17:00, Tuesday, March 10 | Level 0 | Room C
Probiodrug AG Germany Visit their website Connect on partnering360  
CNS/Neurology | 12:15, Tuesday, March 10 | Level 0 | Room E
Qrono Inc. United States Visit their website Connect on partnering360  
Next Generation - Delivery | 12:00, Tuesday, March 10 | Level 0 | Room D
R-Pharm United States   Connect on partnering360  
Cancer | 12:45, Tuesday, March 10 | Level 0 | Room C
Radius Health, Inc. United States Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 17:00, Tuesday, March 10 | Level 0 | Room E
RedHill Biopharma Israel Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 17:15, Tuesday, March 10 | Level 0 | Room E
Resverlogix Corp. Canada Visit their website Connect on partnering360  
Cardiovascular | 11:45, Tuesday, March 10 | Level 0 | Room E
Rexahn Pharmaceuticals, Inc. United States Visit their website Connect on partnering360  
Cancer | 14:15, Tuesday, March 10 | Level 0 | Room C
RIBOLUTION Germany Visit their website    
Next Generation - Biomarkers/Diagnostics/Imaging | 10:40, Tuesday, March 10 | Level 0 | Room D
Roche Switzerland Visit their website Connect on partnering360  
Large Pharma | 14:45, Monday, March 9 | Level 0 | Room E
Rottapharm Biotech S.r.l. Italy   Connect on partnering360  
Autoimmune/Inflammation | 16:00, Tuesday, March 10 | Level 0 | Room C
Sanofi France Visit their website Connect on partnering360  
Large Pharma | 15:30, Monday, March 9 | Level 0 | Room E
Selvita Poland Visit their website Connect on partnering360  
Cancer | 10:00, Tuesday, March 10 | Level 0 | Room C
Servier France Visit their website Connect on partnering360  
Midsize Pharma | 15:45, Tuesday, March 10 | Level 0 | Room D
Shire United States Visit their website Connect on partnering360  
Large Pharma | 16:45, Monday, March 9 | Level 0 | Room E
Sirona Biochem Corp. Canada Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 09:45, Wednesday, March 11 | Level 0 | Room C
Skyepharma Switzerland Visit their website Connect on partnering360  
Midsize Pharma | 14:15, Tuesday, March 10 | Level 0 | Room D
ST Pharm Korea, South Visit their website Connect on partnering360  
Discovery Platform | 09:00, Tuesday, March 10 | Level 0 | Room D
STARPHARMA Australia Visit their website Connect on partnering360  
Enabling Technologies | 16:45, Tuesday, March 10 | Level 0 | Room E
Stemmatters Portugal Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 11:15, Wednesday, March 11 | Level 0 | Room C
SynAffix BV Netherlands Visit their website Connect on partnering360  
Cancer | 14:30, Tuesday, March 10 | Level 0 | Room C
Syncrosome France Visit their website Connect on partnering360  
Services/CRO | 15:45, Tuesday, March 10 | Level 0 | Room E
Takeda Pharmaceutical Company Ltd. Japan Visit their website Connect on partnering360  
Large Pharma | 16:00, Monday, March 9 | Level 0 | Room E
The Institut Carnot CALYM (consortium for the acceleration of innovation and its transfer to the field of Lymphoma) France Visit their website Connect on partnering360  
Academic Innovators | 09:50, Tuesday, March 10 | Level 0 | Room E
The Institut Carnot Curie Cancer France   Connect on partnering360  
Academic Innovators | 10:00, Tuesday, March 10 | Level 0 | Room E
The Institut Carnot Pasteur MI France      
Academic Innovators | 10:10, Tuesday, March 10 | Level 0 | Room E
The Institut Carnot Spine & Brain Institute (ICM) France      
Academic Innovators | 10:20, Tuesday, March 10 | Level 0 | Room E
The Institut Carnot Voir & Entendre France   Connect on partnering360  
Academic Innovators | 09:40, Tuesday, March 10 | Level 0 | Room E
Theravectys France Visit their website Connect on partnering360  
Regen Med/Advanced Therapies | 11:00, Wednesday, March 11 | Level 0 | Room C
ValiSeek Limited United Kingdom Visit their website Connect on partnering360  
Next Generation - Cancer | 11:30, Tuesday, March 10 | Level 0 | Room D
VAXIMM Germany Visit their website Connect on partnering360  
Cancer | 15:00, Tuesday, March 10 | Level 0 | Room C
Zoetis Inc France Visit their website Connect on partnering360  
Midsize Pharma | 14:30, Tuesday, March 10 | Level 0 | Room D
Arrow Up


© 2009–2015 EBD GmbH
BIO-Europe Spring EBD Group BIO Image Map